Results 351 to 360 of about 11,447,845 (407)
Some of the next articles are maybe not open access.

Drug–drug interaction with statins

Expert Review of Clinical Pharmacology, 2008
3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins: atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well-established class of drugs in the treatment of hypercholesterolemia. Statin monotherapy is generally well tolerated, with a low frequency of adverse events.
A. Corsini, S. Bellosta
openaire   +2 more sources

DSN-DDI: an accurate and generalized framework for drug-drug interaction prediction by dual-view representation learning

Briefings Bioinform., 2023
Zimeng Li   +5 more
semanticscholar   +1 more source

MDF-SA-DDI: predicting drug-drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism

Briefings Bioinform., 2021
Shenggeng Lin   +10 more
semanticscholar   +1 more source

Avoiding Drug-Drug Interactions

Chemotherapy, 2009
<i>Background:</i> Drugs may be prescribed in combinations causing drug-drug interactions (DDI) and adverse drug reactions (ADR), resulting in hospital care. <i>Methods:</i> To provide prescribers of drug therapy with a better knowledge of individuals’ current drug therapy, governments have started to collect prescribing data ...
openaire   +2 more sources

Drug-drug interaction prediction with learnable size-adaptive molecular substructures

Briefings Bioinform., 2021
Arnold K. Nyamabo   +3 more
semanticscholar   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Drug Interactions

Pediatrics in Review, 2006
C. Tom-Revzon, H. M. Adam
openaire   +2 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Home - About - Disclaimer - Privacy